Gąbka-Buszek, A.; Kwiatkowska-Borowczyk, E.; Jankowski, J.; Kozłowska, A.K.; Mackiewicz, A.
Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanosphere-Derived Stem-Like Cells Display High Efficacy in a murine Tumor Rejection Model. Vaccines 2020, 8, 147.
https://doi.org/10.3390/vaccines8020147
AMA Style
Gąbka-Buszek A, Kwiatkowska-Borowczyk E, Jankowski J, Kozłowska AK, Mackiewicz A.
Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanosphere-Derived Stem-Like Cells Display High Efficacy in a murine Tumor Rejection Model. Vaccines. 2020; 8(2):147.
https://doi.org/10.3390/vaccines8020147
Chicago/Turabian Style
Gąbka-Buszek, Agnieszka, Eliza Kwiatkowska-Borowczyk, Jakub Jankowski, Anna Karolina Kozłowska, and Andrzej Mackiewicz.
2020. "Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanosphere-Derived Stem-Like Cells Display High Efficacy in a murine Tumor Rejection Model" Vaccines 8, no. 2: 147.
https://doi.org/10.3390/vaccines8020147
APA Style
Gąbka-Buszek, A., Kwiatkowska-Borowczyk, E., Jankowski, J., Kozłowska, A. K., & Mackiewicz, A.
(2020). Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanosphere-Derived Stem-Like Cells Display High Efficacy in a murine Tumor Rejection Model. Vaccines, 8(2), 147.
https://doi.org/10.3390/vaccines8020147